NSE: TATACHEM
TATA CHEMICALS LTD
Price history
-13.91% over 3M
Performance
52-week range
Position in day range
TATACHEM stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Downtrend
50-DMA ₹638.27
RSI (14)
44
Neutral momentum
Volatility (ATR)
4.03%
High
Close streak
1d up
Volume vs 20d avg
0.34x
From 52W high
-34.81%
Up from 52W low
+5.08%
Green days (20)
4/20
Monthly seasonality
Average monthly move for TATACHEM across the available price history.
Key statistics
Open
590
Day high
607.8
Day low
588.8
Prev close
595.45
Volume
7.53 L
Avg vol (20d)
22.17 L
52W high
915.15
52W low
570.05
TATACHEM quarterly results
All TATACHEM results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹4,255 cr
+14.4% YoY
Net profit
-₹17 cr
-106.7% YoY
Operating profit
₹219 cr
-40.7% YoY
EPS
₹-0.67
-106.8% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹4,255 cr | ₹219 cr | -₹17 cr | 5.1% | -0.4% | ₹-0.67 | -106.7% | +99.2% |
| Q4 FY262026-03-31 | ₹3,438 cr | -₹69 cr | -₹2,132 cr | -2.0% | -62.0% | ₹-83.68 | -3707.1% | -2192.5% |
| Q3 FY262025-12-31 | ₹3,550 cr | ₹52 cr | -₹93 cr | 1.5% | -2.6% | ₹-3.65 | — | -136.9% |
| Q1 FY262025-06-30 | ₹3,719 cr | ₹369 cr | ₹252 cr | 9.9% | 6.8% | ₹9.89 | — | +550.0% |
| Q4 FY252025-03-31 | ₹3,509 cr | ₹34 cr | -₹56 cr | 1.0% | -1.6% | ₹-2.19 | — | — |
| TTM (last 4 quarters) | ₹14,962 cr | ₹571 cr | -₹1,990 cr | 3.8% | -13.3% | ₹-78.11 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Tata Chemicals Share Price Ended Higher to ₹617.40: What Is Driving TATACHEM After Today's Close, and the Levels That Matter
Tata Chemicals (TATACHEM) last traded at ₹617.40, +9.60 (+1.58%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Tata Chemicals Share Price Crashes 9.27% on IPO News — What It Means for Investors
Tata Chemicals (TATACHEM) trades at ₹713.20, -66.10 (-9.27%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Tata Chemicals Share Price Jumps 5.53% to ₹774.65 Today — Volumes, 52-Week Range and What to Watch Next
Tata Chemicals (TATACHEM) trades at ₹774.65, +42.85 (+5.53%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Tata Chemicals Zooms 16.66% After IPO Update — Levels, Volumes and the Follow-Up to Track
Tata Chemicals (TATACHEM) trades at ₹734.90, +122.45 (+16.66%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
TATACHEM in Focus: Tata Chemicals Share Price Edges Lower to ₹625.10 on Rising Newsflow
Tata Chemicals (TATACHEM) trades at ₹625.10, -16.25 (-2.60%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Tata Chemicals Edges Up to ₹641.35 — Should Investors Read This as a Trend or a One-Day Move?
Tata Chemicals (TATACHEM) trades at ₹641.35, +7.40 (+1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Tata Chemicals Share Price Edges Up to ₹641.35: What Is Driving TATACHEM Today, and the Levels That Matter
Tata Chemicals (TATACHEM) trades at ₹641.35, +7.40 (+1.15%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Tata Chemicals Sees 2.0x Volume Spike After Order Win Update — Levels, Volumes and the Follow-Up to Track
Tata Chemicals (TATACHEM) trades at ₹655.75, +11.60 (+1.77%). The order-win trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Tata Chemicals Share Price Sees 2.0x Volume Spike on Order Win News — What It Means for Investors
Tata Chemicals (TATACHEM) trades at ₹655.75, +11.60 (+1.77%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Latest market news
Why United Breweries Share Price Traded Flat at ₹1,136.20 After Today's Close: the Quarterly Results Trigger, Explained
United Breweries (UBL) last traded at ₹1,136.20, +0.00 (+0.00%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Canara Bank Q2 FY27 Results: Net Profit ₹5,175 cr, Revenue from operations ₹35,159 cr
Canara Bank (CANBK) reported Standalone Q2 FY27 revenue from operations of ₹35,159 cr and net profit of ₹5,175 cr. Official figures, comparisons and disclosure details.
Indian Bank Q2 FY27 Results: Net Profit ₹3,462 cr, Revenue from operations ₹19,106 cr
Indian Bank (INDIANB) reported Standalone Q2 FY27 revenue from operations of ₹19,106 cr and net profit of ₹3,462 cr. Official figures, comparisons and disclosure details.
Punjab National Bank Q2 FY27 Results: Net Profit ₹5,532 cr, Revenue from operations ₹34,585 cr
Punjab National Bank (PNB) reported Standalone Q2 FY27 revenue from operations of ₹34,585 cr and net profit of ₹5,532 cr. Official figures, comparisons and disclosure details.
Havells India Limited Q2 FY27 Results: Net Profit ₹349 cr, Revenue from operations ₹6,432 cr
Havells India Limited (HAVELLS) reported Consolidated Q2 FY27 revenue from operations of ₹6,432 cr and net profit of ₹349 cr. Official figures, comparisons and disclosure details.
Colgate Palmolive (India) Limited Q2 FY27 Results: Net Profit ₹342 cr, Revenue from operations ₹1,706 cr
Colgate Palmolive (India) Limited (COLPAL) reported Standalone Q2 FY27 revenue from operations of ₹1,706 cr and net profit of ₹342 cr. Official figures, comparisons and disclosure details.
Price and history data from NSE via Upstox. For information only, not investment advice.